Frontotemporal Dementia: What Caregivers Need to Know
Share
Ā
Ā
Ā
By Heather Robbins, Founder ā Robbins Nest Alliance
Frontotemporal dementia does not look like what most people picture when they hear the word dementia. There is no early memory loss. There is no confusion about where they are or what year it is. What there is, and what blindsides families, is a complete change in who their person is. Their personality. Their judgment. Their ability to feel anything for the people around them.
It hits younger. It moves fast. And it gets mistaken for a psychiatric disorder more often than almost any other dementia. Families spend years in the wrong system before anyone gets it right.
This article covers what FTD is, how it presents, why it is so commonly misdiagnosed, and what the evidence says about managing it.
For an overview of all major dementia types, see our master guide in Nest Academy. For more on Lewy body dementia, see our Brain Injury 101 deep dive.
What Is Frontotemporal Dementia
Frontotemporal dementia (FTD) is a neurodegenerative disorder caused by progressive deterioration of the frontal and temporal lobes of the brain. These are the regions that govern personality, behavior, social judgment, emotional regulation, and language. When they degenerate, those functions go with them.
FTD is the second most common cause of early-onset dementia after Alzheimer's disease. Most people with FTD develop symptoms in their 50s, though onset can occur earlier or later. Memory, the thing most people associate with dementia, is often preserved in the early stages. That is part of why it gets missed.
There are three main subtypes:
- Behavioral variant FTD (bvFTD) ā the most common subtype. Characterized by personality change, social dysfunction, disinhibition, apathy, and loss of empathy.
- Semantic variant primary progressive aphasia (svPPA) ā affects the ability to understand and use word meanings. The person loses the meaning of words, even familiar ones.
- Nonfluent variant primary progressive aphasia (nfvPPA) ā affects speech production. The person knows what they want to say but struggles increasingly to get it out. Speech becomes halting, effortful, and eventually minimal.
Why FTD Is Not What People Expect
Most dementia education is built around Alzheimer's disease, memory loss, confusion, disorientation. FTD breaks that template completely.
In behavioral variant FTD, the early symptoms are behavioral and social. The person may become socially inappropriate, saying things that would normally be filtered, touching strangers, making offensive comments without awareness that they are offensive. They may develop compulsive behaviors, food fixations, or a dramatic increase in appetite for sweets. They may become completely apathetic, not sad, just empty of motivation or interest in the people and things they previously cared about.
Research from the UCSF Memory and Aging Center documents that apathy is often the first symptom reported by caregivers and is routinely mistaken for depression. The distinction matters because the two conditions have different mechanisms and different management approaches.
The person typically has little to no insight into their own changes. They do not experience themselves as different. They do not register the impact their behavior has on others. This is not denial. The part of the brain that generates self-awareness is the part that is damaged.
Why It Gets Mistaken for a Psychiatric Disorder
This is the part that derails families most.
Personality change, social withdrawal, disinhibition, impulsivity, emotional flatness, these all map onto psychiatric diagnoses. Depression. Bipolar disorder. Schizophrenia. People with FTD, particularly younger people with FTD, end up in psychiatric care. They get medications for conditions they do not have. Those medications do not work. Years pass.
A case report published in ScienceDirect documented a 31-year-old patient initially diagnosed with schizophrenia and catatonia who was later correctly identified as having behavioral variant FTD. The young age of onset was the primary reason the correct diagnosis was delayed. His symptoms did not respond to psychiatric medications or electroconvulsive therapy. It was neuroimaging that finally changed the diagnosis.
If your person has a psychiatric diagnosis, has not responded to psychiatric treatment, and is showing progressive behavioral and language changes, push for a neurological evaluation. FTD requires neuroimaging and neuropsychological testing. A psychiatrist alone cannot rule it out.
Genetic Component
FTD has a stronger genetic component than most other dementias. Approximately 30 to 40 percent of FTD cases have a family history of the disease. Known genetic mutations include those in the GRN, MAPT, and C9orf72 genes. For families where FTD has appeared in a parent or sibling, genetic counseling is a reasonable conversation to have with a specialist.
Diagnosis
FTD diagnosis is based on clinical presentation, neuropsychological testing, and neuroimaging. MRI typically shows frontal and temporal lobe atrophy. FDG-PET imaging can show reduced metabolic activity in those regions even before structural changes are visible on MRI.
There is no single definitive biomarker test for FTD in routine clinical practice. Diagnosis requires a specialist, typically a behavioral neurologist or neuropsychologist with experience in frontotemporal disorders. General practitioners and even general neurologists can miss it.
Research published in PMC on caregiver perspectives in bvFTD confirmed that standard cognitive and functional measures used in most dementia evaluations fail to detect the dominant behavioral and social cognitive deficits that define FTD. The wrong tools produce the wrong answer.
Management: What the Evidence Supports
There is no approved disease-modifying treatment for FTD. Management is behavioral, environmental, and supportive.
Behavioral symptoms. Disinhibition, compulsive behaviors, and agitation are the most challenging features to manage. SSRIs have been used with some benefit for compulsive behaviors and irritability, though evidence is limited. Antipsychotics carry significant risks and should be used with caution and specialist oversight.
Language symptoms. Speech-language therapy is the primary intervention for the language variants of FTD. The goal shifts over time from improving communication to maintaining it and then to developing alternative communication strategies as verbal output declines.
Environmental management. Predictable routines, low-stimulation environments, and clear physical structure reduce the frequency and severity of behavioral episodes. Removing access to financial accounts, car keys, and other areas of potential impulsive harm is a practical safety measure that the research consistently supports ā not a punitive one.
Caregiver support. FTD caregiver burden is documented as among the highest of any dementia type ā driven by the behavioral symptoms, the younger age of onset, the loss of the person's personality before their physical health declines, and the frequent absence of appropriate support services for younger patients. Research on bvFTD caregiver self-care confirms that caregivers in this population defer their own needs at significantly higher rates than in other dementia populations, with measurable consequences for their own health.
If you are caring for someone with FTD, caregiver support is not optional. It is a clinical priority.
What to Tell Your Care Team
If you are observing the following, document them and bring them to a specialist:
- Personality changes that feel like a different person ā not a worse version, a different one
- Loss of empathy or emotional connection to family members
- Socially inappropriate behavior that the person seems unaware of
- Compulsive or repetitive behaviors
- New food fixations, particularly for sweets
- Progressive language difficulties, word finding, speech production, or word comprehension
- Psychiatric treatment that is not working
- Family history of FTD, ALS, or early-onset dementia
Ask specifically for a behavioral neurology referral and neuroimaging. A standard memory clinic evaluation may not be sufficient.
Related RNA Resources
- Nest Academy: Types of Dementia ā Master Guide
- Brain Injury 101: Lewy Body Dementia
- Brain Injury 101: Sundowning in Dementia
- Brain Injury 101 ā Full Educational Library
- Veterans Blog: Dementia and Family Support
š¬ Free Weekly Education ā From the Nest
From the Nest delivers peer-reviewed brain injury and dementia education every Wednesday at 7am ET ā translated for caregivers, not clinicians. Free. No spam.
Peer-Reviewed Sources
- Dattola S, et al. Frontotemporal dementia: a systematic review of artificial intelligence approaches in differential diagnosis. Frontiers in Aging Neuroscience. 2025;17:1547727.
- Vijverberg EGB, et al. A caregiver's perspective on clinically relevant symptoms in behavioural variant frontotemporal dementia. Alzheimer's and Dementia: Translational Research and Clinical Interventions. 2023.
- Krudop WA, et al. Clinical phenotypes of behavioral variant frontotemporal dementia by age at onset. Journal of Alzheimer's Disease. 2021.
- Moretti R, et al. Neuropsychiatric symptoms in behavioral variant frontotemporal dementia and Alzheimer's disease: a 12-month follow-up study. Frontiers in Neurology. 2021.
- UCSF Memory and Aging Center. Behavioral Variant Frontotemporal Dementia. memory.ucsf.edu.
- National Institute on Aging. Frontotemporal Disorders: Information for Patients, Families, and Caregivers. nia.nih.gov.
All sources are peer-reviewed or from established medical institutions. Robbins Nest Alliance does not provide medical advice. Consult your physician or care team for diagnosis and treatment decisions.